Compare GYGY & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GYGY | BEAT |
|---|---|---|
| Founded | N/A | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.5M | 27.7M |
| IPO Year | 2026 | 2021 |
| Metric | GYGY | BEAT |
|---|---|---|
| Price | $0.96 | $0.42 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.63 |
| AVG Volume (30 Days) | ★ 3.5M | 313.2K |
| Earning Date | N/A | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.07 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $315.97 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.04 | $0.39 |
| 52 Week High | $11.81 | $4.00 |
| Indicator | GYGY | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 11.62 | 36.81 |
| Support Level | N/A | N/A |
| Resistance Level | $2.06 | $0.52 |
| Average True Range (ATR) | 0.19 | 0.03 |
| MACD | 0.20 | -0.00 |
| Stochastic Oscillator | 4.47 | 26.02 |
Game Your Game Inc develops and markets AI-based sports performance tracking technology that is prominently focused on the golf industry. Its products include GPS shot tracking hardware, AI algorithms, and a smart coaching app to provide players with real-time insights, recommendations, and personalized performance analytics. The company's technology consists of the GameGolf KZN AI platform, which is an integrated golf performance ecosystem of proprietary shot-tracking hardware and subscription-based software solutions. It generates revenue from the sale of KZN AI hardware device and from recurring annual subscription fees for continued access to the GameGolf App, GameGolf Smart Caddie and the GameGolf platform. Geographically, the company operates mainly in the United States and Europe.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.